GXJ
RPRX icon

Global X Japan’s Royalty Pharma RPRX Stock Holding History

Global X Japan’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.3K Sell
416
-52
-11% -$2.71K ﹤0.01% 278
2026
Q1 		$22.4K Sell
468
-90
-16% -$3.94K ﹤0.01% 257
2025
Q4 		$21.6K Buy
558
+129
+30% +$4.92K ﹤0.01% 226
2025
Q3 		$15.1K Sell
429
-145
-25% -$5.25K ﹤0.01% 261
2025
Q2 		$20.7K Buy
574
+160
+39% +$5.3K ﹤0.01% 199
2025
Q1 		$12.9K Sell
414
-45
-10% -$1.43K ﹤0.01% 255
2024
Q4 		$11.7K Buy
459
+99
+28% +$2.63K ﹤0.01% 245
2024
Q3 		$10.2K Buy
+360
New +$9.97K ﹤0.01% 266

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global X Japan's RPRX Position: Q2 2026 in Review

Global X Japan reduced its Royalty Pharma (RPRX) stake by 11% in Q2 2026, selling an estimated $2.71K and leaving 416 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #278.

Global X Japan first reported a position in RPRX in Q3 2024 and has held it in 8 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Global X Japan held 416 shares of Royalty Pharma worth $23.3K as of Q2 2026.
  • Global X Japan sold 52 Royalty Pharma shares in Q2 2026, an estimated $2.71K.
  • Royalty Pharma made up ﹤0.01% of Global X Japan's portfolio in Q2 2026, its #278 holding.
  • Global X Japan first reported a position in Royalty Pharma in Q3 2024 and has held it in 8 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.